Who owns 4D Molecular Therapeutics, Inc.?
Institutional ownership of FDMT from SEC Form 13F filings across 111 reporting managers. All positions are from one synchronized reporting period — 2026-06-30 books, filed up to 45 days after quarter end — so every row is comparable.
111
13F holders
$408.9M
value, 2026 filers
59.5%
of shares outstanding (31.1M sh)
20
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-06-30· % of fund = share of the manager's own book · % of co. = share of FDMT's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | Jupiter Topco LLCNEW | 5.7M | $76.5M | 0.0% | 11% | new |
| 2 | BlackRock, Inc. | 4.5M | $60.5M | 0.0% | 8.7% | +9.7% |
| 3 | GOLDMAN SACHS GROUP INC | 4.3M | $56.6M | 0.0% | 8.1% | +1.3% |
| 4 | ADAGE CAPITAL PARTNERS GP, L.L.C. | 2.2M | $29.9M | 0.0% | 4.3% | +40.1% |
| 5 | VANGUARD CAPITAL MANAGEMENT LLC | 2.1M | $27.9M | 0.0% | 4% | -4.4% |
| 6 | GEODE CAPITAL MANAGEMENT, LLC | 1.1M | $15.0M | 0.0% | 2.2% | +5.9% |
| 7 | BANK OF AMERICA CORP /DE/ | 1.1M | $14.9M | 0.0% | 2.1% | +15.0% |
| 8 | DEUTSCHE BANK AG\ | 710,942 | $9.5M | 0.0% | 1.4% | +0.4% |
| 9 | CITADEL ADVISORS LLC | 687,597 | $9.1M | 0.0% | 1.3% | +160.4% |
| 10 | VANGUARD PORTFOLIO MANAGEMENT LLC | 579,903 | $7.7M | 0.0% | 1.1% | +4.3% |
| 11 | NORTHERN TRUST CORP | 562,929 | $7.5M | 0.0% | 1.1% | +64.6% |
| 12 | Nuveen, LLC | 503,071 | $6.7M | 0.0% | 1% | -10.5% |
| 13 | MORGAN STANLEY | 503,020 | $6.7M | 0.0% | 1% | +45.6% |
| 14 | Catalio Capital Management, LPNEW | 471,254 | $6.3M | 1.2% | 0.9% | new |
| 15 | Schonfeld Strategic Advisors LLC | 407,470 | $5.4M | 0.0% | 0.8% | +303.0% |
| 16 | JPMORGAN CHASE & CO | 402,137 | $5.2M | 0.0% | 0.8% | -3.3% |
| 17 | Sixth Street Partners Management Company, L.P.NEW | 339,275 | $4.5M | 0.8% | 0.6% | new |
| 18 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 339,275 | $4.5M | 0.0% | 0.6% | +3.3% |
| 19 | VANGUARD FIDUCIARY TRUST CO | 276,238 | $3.7M | 0.0% | 0.5% | +2.6% |
| 20 | Burkehill Global Management, LP | 275,000 | $3.7M | 0.1% | 0.5% | 0.0% |
| 21 | UBS Group AG | 256,673 | $3.4M | 0.0% | 0.5% | +62.3% |
| 22 | RAYMOND JAMES FINANCIAL INC | 242,349 | $3.2M | 0.0% | 0.5% | -8.9% |
| 23 | FEDERATED HERMES, INC. | 222,416 | $3.0M | 0.0% | 0.4% | -84.5% |
| 24 | Woodline Partners LP | 200,001 | $2.7M | 0.0% | 0.4% | -50.0% |
| 25 | Brevan Howard Capital Management LPNEW | 176,850 | $2.4M | 0.0% | 0.3% | new |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.